We are excited to be attending the American College of Toxicology (ACT) 2024 annual meeting in Austin, Texas!
ACT is a global community of professional scientists representing the pharmaceutical and biotech industries, regulatory agencies, contract research organizations, academia, and consulting firms. The 45th Annual Meeting will include a wide-ranging scientific program and educational courses, with distinguished plenary speakers, the popular Poster Session, an Awards Ceremony, and multiple professional networking events.
We are pleased to announce that Lhasa will be holding an industry hosted session discussing:
Setting limits for nitrosamines and other impurity classes using in silico approaches, including read-across.
Tuesday 19th November, 12:00 – 12:55
Join us to evaluate the toxicological risks posed by nitrosamines and other impurity classes. Discover how the Lhasa carcinogenic potency categorisation approach (CPCA) tool can support your impurity assessment, and how to determine compound-relevant limits for these impurity types using a transparent in silico read-across workflow.
This session will be hosted by Senior Application Scientist, Charlie Modlin.
Location: Room 201
We will also be exhibiting at the meeting in Booth 313 – we can’t wait to see you there!